Rxo (RXO) Gross Margin (2021 - 2026)

Rxo (RXO) has reported Gross Margin for 6 consecutive years, with 17.82% the latest figure, recorded in Q1 2026.

• Gross Margin for Q1 2026 came in at 17.82%, down 171.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 19.27% (down 146.0% YoY), and the FY2025 annual result was 19.7%, down 195.0% from the prior year.
• Gross Margin was 17.82% for Q1 2026 at Rxo, down from 18.11% in the prior quarter.
• Over five years, Gross Margin peaked at 26.26% in Q2 2022 and troughed at 17.82% in Q1 2026.
• Average Gross Margin over 5 years is 22.43%, with a median of 23.44% recorded in 2024.
• Year-over-year, Gross Margin soared 466 bps in 2022 and slumped 543 bps in 2024.
• Over 5 years, Gross Margin stood at 24.82% in 2022, then declined by 3 bps to 24.03% in 2023, then slipped by 23 bps to 18.6% in 2024, then declined by 3 bps to 18.11% in 2025, then dropped by 2 bps to 17.82% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 17.82% in Q1 2026, 18.11% in Q4 2025, and 19.99% in Q3 2025.